Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 107 companies set new 52-week lows.
InMed Launches Cannabicitran, Expanding Its Rare Cannabinoid Portfolio For The Health And Wellness Sector
InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (NASDAQ:INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, is pleased to announce it has
HC Wainwright & Co. Initiates Coverage On InMed Pharmaceuticals with Buy Rating, Announces Price Target of $6
HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on InMed Pharmaceuticals (NASDAQ:INM) with a Buy rating and announces Price Target of $6.
54 Biggest Movers From Yesterday
Gainers
Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of hypoplastic left heart syndrome.
Welcome to the Party $INM! Competition or Compliment to $SNDL? — Cannabis Daily November 18, 2021
The Best Daily Overview Of The Cannabis Space
South Dakota lawmakers recommend bill to legalize marijuana.
New York bans advertising for cannabis and psychedelics in subways.
Rep. Nancy Mace's history with cannabis.
In today's episode we covered the following public companies:
44 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Longeveron Inc. (NASDAQ: LGVN) jumped 157% to $7.51. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of hypoplastic left heart syndrome.
